About Pudee

Reliability, Responsibility and Rapidity

Founded in 2007, focus on the synthesis of small molecule compounds and the extraction of some natural compounds. We develop, produce and sell high-quality advanced intermediates and some APIs with competitive prices.
Get Appointment

Contact Info

  • Building 2, Handa Science and Technology Park
    No. 8 Pioneer Road
    High-tech Zone. Suzhou.
  • 86 512 6803 2792
    86 512 6803 2791
  • willdyhan@pudeepharm.com
    sales@pudeepharm.com

Product Details

Enasidenib

Enasidenib | 1446502-11-9

Chemical Name: 2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol

CAS Number: 1446502-11-9
Formula: C19H17F6N7O
Molecular weight: 473.38
  • Category:

Product Description

Enasidenib is an inhibitor of IDH2. It is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene. The drug was discovered in 2009 by scientists at Agoios and the development names for the drug was AG-221 and CC-90007.

Enasidenib was approved by the FDA in August 2017. The trade name under which it was approved was Idhifa.

6-[6-(Trifluoromethyl)-2-pyridinyl]-1,3,5-triazine-2,4(1H,3H)-dione is one of KMS of Enasidenib, the appearance is white to off-white powder solid, the purity is not less than 98% by HPLC. the Purity of API (Enasidenib) is not less than 99.5%